Hodgkin Lymphoma Most Often Mistaken for TB, 90.2% of Asian Pediatric Oncologists Say

A Cureus survey found 90.2 percent of Asian pediatric oncologists say Hodgkin lymphoma is the malignancy most often mistaken for tuberculosis.

Childhood cancer and tuberculosis frequently collide across Asia, where empirical antitubercular treatments often delay vital oncologic diagnoses, Cureus reported.

A cross-sectional, web-based survey conducted between July and September 2023 captured insights from 41 pediatric oncology physicians practicing across 25 countries. All respondents managed both hematologic malignancies and solid tumors. The findings reveal how overlapping symptoms complicate clinical pathways in regions with high disease burdens.

Proven tuberculosis coexisting with cancer appeared in fewer than 10 percent of patients. Yet, clinicians frequently encountered empirical antitubercular therapy given before a cancer diagnosis.

Hodgkin lymphoma emerged as the malignancy most often mistaken for tuberculosis, cited by 90.2 percent of respondents, or 37 physicians. Non-Hodgkin lymphoma followed at 46.3 percent, while leukemias stood at 19.5 percent. Shared constitutional signs like prolonged fevers and weight loss drove these errors.

Physicians also pointed to overlapping radiological findings, particularly mediastinal or abdominal lymphadenopathy. These similarities frequently prompt clinicians to start empirical treatments before securing definitive tissue diagnoses.

Treatment delivery suffers once both conditions are managed concurrently. Drug interactions force adjustments that complicate oncologic care.

Treatment interruptions related to drug-drug interactions were reported by 65.8 percent of respondents, representing 27 clinicians. 44 percent, or 18 physicians, reported modifying cancer therapy intensity to cope with the dual diagnoses.

Pediatric Oncology Survey Findings on Tuberculosis Overlap
Clinical Challenge Respondent Percentage Number of Physicians (n)
Hodgkin lymphoma misdiagnosed as TB 90.2% 37
Treatment interruptions from drug interactions 65.8% 27
Modification of cancer therapy intensity 44.0% 18

Routine screening for tuberculosis prior to starting chemotherapy remains uncommon across participating centers. Screening mostly happens selectively before hematopoietic stem cell transplantation. Physicians rely primarily on tuberculin skin testing alongside chest radiography for those specific cases.

Cureus, the open-access journal publishing the survey, began as PeerEMed in 2009 and adopted its current name in December 2012. Founding editors-in-chief John R. Adler of Stanford University and Alexander Muacevic of LMU Munich introduced a model combining pre-publication peer review with an optional post-publication Scholarly Impact Quotient. The journal joined the Springer Nature group in December 2022 and does not charge publication fees when certain criteria are met.

Future prospective studies aim to evaluate these diagnostic pathways and treatment modifications. Researchers hope to establish clearer protocols for integrated care in endemic settings.

More on this


Discover more from Archyworldys

Subscribe to get the latest posts sent to your email.